The Effects of Tele-Yoga in Ankylosing Spondylitis Patients
Launched by DOKUZ EYLUL UNIVERSITY · Mar 16, 2021
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
Yoga is an ancient discipline that emerged in India thousands of years ago, designed to bring balance and health to the physical, mental, emotional and spiritual dimensions of the individual.Due to its therapeutic effects, yoga can be considered as an alternative approach for those with rheumatic disease. Because of Covid-19, which has changed the world and the lifestyle of people, tele-yoga practice can be considered as an alternative instead of traditional face-to-face yoga classes. The use of online platforms provides a good environment for yoga training at home. The aim of this study is...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ankylosing spondylitis(AS) patients diagnosed according to modified New York criteria
- • To be volunteer
- • To have the necessary equipment to provide internet access and connection
- Exclusion Criteria:
- • Presence of systemic, orthopedic neurological or cognitive disease other than ankylosing spondylitis
- • Regular exercise in the last 3 months
- • Pregnancy
- • Not attending 4 consecutive yoga sessions
- • Changing the drug during the study
- • Has an acute attack during the study
About Dokuz Eylul University
Dokuz Eylul University is a prominent educational institution located in İzmir, Turkey, recognized for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct cutting-edge research aimed at improving patient outcomes. With a focus on interdisciplinary collaboration and adherence to ethical standards, Dokuz Eylul University strives to contribute valuable insights to the medical community while fostering the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Trial Officials
YASEMİN ACAR
Principal Investigator
Dokuz Eylul University
NURSEN İLÇİN
Study Director
Dokuz Eylul University
İSMAİL SARI
Study Chair
Dokuz Eylul University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials